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Abstract
The effect of drug on a person may be different than expected 
because that drug interacts with another drug the person is taking 
(drug-drug  interaction),  food,  beverages,  dietary  supplements 
the  person  is  consuming  (drug-nutrient/food  interaction)  or 
another disease the person has (drug-disease interaction). A drug 
interaction is a situation in which a substance affects the activity of 
a drug, i.e. the effects are increased or decreased, or they produce a 
new effect that neither produces on its own. These interactions may 
occur out of accidental misuse or due to lack of knowledge about 
the active ingredients involved in the relevant substances. Regarding 
food-drug  interactions  physicians  and  pharmacists  recognize 
that some foods and drugs, when taken simultaneously, can alter 
the body's ability to utilize a particular food or drug, or cause 
serious side effects. Clinically significant drug interactions, which 
pose potential harm to the patient, may result from changes in 
pharmaceutical, pharmacokinetic, or pharmacodynamic properties. 
Some may be taken advantage of, to the benefit of patients, but 
more commonly drug interactions result in adverse drug events. 
Therefore it is advisable for patients to follow the physician and 
doctors instructions to obtain maximum benefits with least food-
drug interactions. The literature survey was conducted by extracting 
data  from  different  review  and  original  articles  on  general  or 
specific drug interactions with food. This review gives information 
about various interactions between different foods and drugs and 
will help physicians and pharmacists prescribe drugs cautiously 
with only suitable food supplement to get maximum benefit for the 
patient.
Keywords:  Food-drug  interaction;  Cytochrome  P450;  Drug; 
Chelation.
Introduction
Medicines  can  treat  and  cure  many  health  problems. 
However, they must be taken properly to ensure that they are safe 
and effective. Medications should be extremely specific in their 
effects, have the same predictable effect for all patients, never be 
affected by concomitant food or other medications, exhibit linear 
potency, be totally non-toxic in any dosage and require only a single 
dose to affect a permanent cure. However, this ideal drug is still to 
be discovered.1
Many medicines have powerful ingredients that interact with 
the human body in different ways. Diet and lifestyle can sometimes 
have a significant impact on drugs. A drug interaction is a situation 
in which a substance affects the activity of a drug, i.e. the effects are 
increased or decreased, or they produce a new effect that neither 
produces on its own. Typically, interactions between drugs come 
to mind (drug-drug interaction). However, interactions may also 
exist between drugs and foods (drug-food interactions), as well as 
drugs and herbs (drug-herb interactions).
These may occur out of accidental misuse or due to lack of 
knowledge about the active ingredients involved in the relevant 
substances. Interactions between food and drugs may inadvertently 
reduce or increase the drug effect. Some commonly used herbs, 
fruits as well as alcohol may cause failure of the therapy up a point 
of to serious alterations of the patient’s health. The majority of 
clinically  relevant  food-drug  interactions  are  caused  by  food-
induced changes in the bioavailability of the drug. 
Major  side-effects  of  some  diet  (food)  on  drugs  include 
alteration in absorption by fatty, high protein and fiber diets.2 
Bioavailability is an important pharmacokinetic parameter which 
is correlated with the clinical effect of most drugs. However, in 
order to evaluate the clinical relevance of a food-drug interaction 
the impact of food intake on the clinical effect of the drug has to 
be quantified as well.
The most important interactions are those associated with a 
high risk of treatment failure arising from a significantly reduced 
bioavailability in the fed state. Such interactions are frequently 
caused by chelation with components in food. In addition, the 
physiological response to food intake, in particular, gastric acid 
secretion,  may  reduce  or  increase  the  bioavailability  of  certain 
drugs.3,4
Drug  interactions  can  alter  the  pharmacokinetics  and/or 
pharmacodynamics of a drug. The pharmacodynamic interaction 
may  be  additive,  synergistic,  or  antagonistic  effects  of  a  drug. 
Drug interactions (DIs) represent an important and widely under 
recognized  source  of  medication  errors.5  The  gastrointestinal 
absorption of drugs may be affected by the concurrent use of other 
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agents that,1 have a large surface area upon which the drug can be 
absorbed,2 bind or chelate,3 alter gastric pH,4 alter gastrointestinal 
motility, or affect transport proteins such as P-glycoprotein. A 
reduction only in absorption rate of a drug is seldom clinically 
important, whereas a reduction in the extent of absorption will be 
clinically important if it results in sub therapeutic serum levels.5
Factors such as nonspecific binding, atypical kinetics, poor 
effector solubility, and varying ratios of accessory proteins may 
alter the kinetic behavior of an enzyme and subsequently confound 
the  extrapolation  of  in  vitro  data  to  the  human  situation.6 
Coenzyme Q-10 (CoQ10) is very widely consumed by humans as 
a food supplement because of its recognition by the public as an 
important nutrient in supporting human health. It interferes with 
intestinal efflux transporter P-glycoprotein (P-gp) and as result 
food-drug interactions arise.7
The interaction of natural products and drugs is a common 
hidden problem encountered in clinical practice. The interactions 
between  natural  products  and  drugs  are  based  on  the  same 
pharmacokinetic and pharmacodynamic principles as drug-drug 
interactions. Several fruits and berries have recently been shown to 
contain agents that affect drug-metabolizing enzymes.8 Grapefruit 
is the most well-known example, but also sevillian orange, pomelo 
and  star  fruit  contain  agents  that  inhibit  cytochrome  P450 
3A4 (CYP3A4), which is the most important enzyme in drug 
metabolism.9
The  study  of  drug-drug,  food-drug,  and  herb-drug 
interactions and of genetic factors affecting pharmacokinetics and 
pharmacodynamics is expected to improve drug safety and will 
enable individualized drug therapy. Drugs can show their efficacy 
only  if  administered  in  appropriate  quantity  with  appropriate 
combination of drugs and foods and at appropriate time. 
In contrast to the easy access to information on drug-drug 
interactions,  the  information  about  food-drug  interaction  is 
not  always  available  conveniently.  It  is  a  difficult  and  complex 
problem to accurately determine the effects of food and nutrients 
on  a  particular  drug.  This  article  aims  to  help  the  healthcare 
professionals specially physicians and pharmacists and patients 
to become more knowledgeable about drug and food interactions.
Electronic search of literatures was conducted over a period 
of two months and all original research and review articles were 
included  in  this  study.  No  literature  was  older  than  20  years. 
The  drugs  were  selected  and  reviewed  on  the  basis  of  their 
general utilization pattern and realizing the need for reporting 
their  interaction  with  different  dietary  supplements  for  better 
therapeutic  use  of  these  drugs  within  the  recommended  dose 
regimen.
Fruit Juices
Among  all  fruit  juices,  grape  fruit  juice  (GFJ)  possesses  high 
interaction with almost all types of drugs. The juice modifies the 
body’s way of metabolizing the medication, affecting the liver’s 
ability to work the drug through a person’s system. Taniguchi 
in 2007 reported a case of purpura associated with concomitant 
ingestion of cilostazol, aspirin and grapefruit juice in 79 years 
old man. His purpura disappeared upon cessation of grapefruit 
juice, although his medication was not altered. The most probable 
cause of his purpura is an increase in the blood level of cilostazol 
because of the inhibition of cilostazol metabolism by components 
of grapefruit juice; Taniguch.9
Numerous reports have documented drug interactions with GFJ 
that occur via inhibition of CYP3A enzymes.10 Furanocoumarins 
present in GFJ inhibit the intestinal CYP 3A4 and have been 
shown to increase the oral bioavailability of medications that are 
CYP 3A4 substrates like Felodipine, midazolam, cyclosporine and 
raise their concentrations above toxic levels.11 
GFJ  is  generally  contraindicated  to  patients  taking 
psychotropics and it is advised to inform patients about described 
interaction.12 The in vitro data suggest that compounds present in 
grapefruit juice are able to inhibit the P-gp activity modifying the 
disposition of drugs that are P-gp substrates such as talinolol.13 
The overall exposure of some drugs can be increased by more than 
fivefold when taken with GFJ and increase the risk of adverse 
effects.14
With new anticonvulsants, serum iron and sodium need to 
be monitored. Additionally, users are advised to avoid drinking 
grape fruit juice within 1-2 hr(s) of taking these anticonvulsants.15 
Furanocoumarines and active bioflavonoids present in GFJ are also 
inhibitors of OATP and when ingested concomitantly, can reduce 
the  oral  bioavailability  of  the  OATP  substrate,  fexofenadine.16 
Overall, a series of flavonoids present in GFJ are identified as 
esterase  inhibitors,  of  which  kaempferol  and  naringenin  are 
shown to mediate pharmacokinetic drug interaction with most 
of the calcium channel antagonist and the statin groups of drugs 
such as enalapril and lovastatin due to their capability of esterase 
inhibition.17
Cholesterol-lowering  agent  lovastatin  should  be  taken  with 
food to enhance gastrointestinal absorption and bioavailability. 
The  absorption  of  rosuvastatin,  another  anti-hyper  lipidemic 
agent, was significantly decreased in the fed state compared with 
the  fasting  state,  which  suggests  that  rosuvastatin  should  be 
administered on an empty stomach.18 
Simvastatin,  Ezetimibe,  pravastatin  and  fluvastatin  may  be 
taken  without  regards  to  food.  However,  high  fiber  diets  may 
lower the efficacy of these drugs.19 Concomitant administration 
of  statins  with  food  may  alter  statin  pharmacokinetics  or 
pharmacodynamics, increasing the risk of adverse reactions such 
as myopathy or rhabdomyolysis or reducing their pharmacological 
action. Consumption of pectin or oat bran together with Lovastatin 
reduces  absorption  of  the  drug,  while  alcohol  intake  does  not 
appear to affect the efficacy and safety of Fluvastatin treatment.20
Warfarin
Warfarin is commonly used to treat or prevent thromboembolic 
events.21  Patients  taking  warfarin  are  at  particular  risk  of 
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interactions  with  dietary  supplements,  yet  approximately  30% 
use herbal or natural product supplements on a regular basis.22 
There  is  a  possible  interaction  between  warfarin  and  a  high-
protein diet. The potential for increased dietary protein intake 
to raise serum albumin levels and/or cytochrome P450 activity 
has been postulated as mechanisms for the resulting decrease in 
international normalized ratio (INRs).23
Some  vegetables  (broccoli,  Brussels  sprouts,  kale,  parsley, 
spinach, and others) are high in vitamin K. Eating large quantities 
or making sudden changes in the amounts eaten of these vegetables, 
interferes with the effectiveness and safety of warfarin therapy.24
Eating  charbroiled  food  may  decrease  warfarin  activity, 
while  eating  cooked  onions  may  increase  warfarin  activity.25 
Soy foods have been reported both to increase and to decrease 
warfarin activity.25 The significance of these last three interactions 
remains  unclear.  The  combination  of  warfarin  administration 
and cranberry juice ingestion appeared to be associated with an 
elevated INR without bleeding in elderly patient.
A number of studies have been documented on the interaction 
of warfarin and cranberry juice.26-30 Cranberry juice is a flavonoid, 
which has been shown to induce, inhibit, or act as a substrate for 
the biosynthesis of several cytochrome P-450 (CYP) isoenzymes. 
Specifically, cranberry juice may inhibit the activity of CYP2C9, 
the primary isoenzyme involved in the metabolism of S-warfarin. 
It was suggested that cranberry juice increased the International 
Normalized  Ratio  (INR)  of  patients  taking  warfarin,  but 
neither  clearly  identified  cranberry  juice  as  the  sole  cause  of 
INR elevation.31 If warfarin sodium is ingested with leafy green 
vegetables, the hypoprothrombinemic effect of warfarin may be 
decreased and thromboembolic complications may develop.32
Monoamnine Oxidases
Antidepressant activity of monoamine oxidase inhibitors (MAOIs) 
was  initially  noted  in  the  1950s.  Although  older  monoamine 
oxidase  inhibitors  (MAOIs)  are  effective  in  the  treatment  of 
depressive disorders, they are under-utilized in clinical practice due 
to main concerns about interaction with tyramine-containing food 
(matured cheese, red vine, ripped bananas, yogurt, shrimp paste 
and salami) or so called cheese reaction, since they are capable of 
producing hypertensive crisis in patients taking MAOIs.33
The  first-generation  MAOIs  such  as  phenelzine  and 
isocarboxazid  were  largely  nonselective  inhibitors  of  both 
subtypes of MAO, MAO (A) and MAO (B). These medications 
carried with them dietary restrictions.34 Tyramine is an indirectly 
acting  sympathomimetic  agent,  is  degraded  by  MAO  but  in 
the presence of MAOIs, it escapes degradation and reaches the 
systemic circulation where it is taken up by the adrenergic neuron, 
leading to a hypertensive crisis.35 However, MAOIs have been well 
established as an effective intervention for people with treatment-
resistant depression, and transdermal formulations may provide 
a  valuable  therapeutic  option  and  eliminate  the  drug-food 
interaction.36
Antihypertensive Drugs
Patients  placed  on  anti  hypertensive  drugs  will  benefit  from 
concomitant moderate sodium restricted diets.23 Propranolol serum 
levels may be increased if taken with rich protein food. A change 
in diet from high carbohydrates/low protein to low carbohydrate/
high  protein  may  result  in  increased  oral  clearance.  Smoking 
may decrease its plasma levels of by increasing its metabolism.37 
The intestinal absorption of celiprolol (beta-blocker) is inhibited 
when it is taken with orange juice. Hesperidin, present in orange 
juice, is responsible for the decreased absorption of celiprolol.38 
The absorption of ACEs inhibitors is increased when taken on 
an empty stomach.39 While GFJ increases the bioavailability of 
felodipine (Ca2 channel blocker).39
 Licorice  extract, a  common  ingredient  of dietary  supplement   
 contains glycyrrhizin and glycyrrhetinic acid. It is a potent inhibitor
 of 11- bet- hydroxyl steroid dehydrogenase, it increases excess of
 cortisol to mineralocorticoid receptors causing sodium retention
 and potassium depletion, so it may interfere with various medicines
 including antihypertensive and antiarrhythmic agents.40,41 A high
 intake  of  liquorice  can  cause  hypermineralocorticoidism  with
 sodium retention and potassium loss, oedema, increased blood
 pressure  and  depression  of  the  renin-angiotensin-aldosterone
 system.42 Studies showed that a daily consumption of glycyrrhizic
 acid of 95 mg or more caused an increase in blood pressure. A
 practical guideline for an acceptable daily intake of glycyrrhizic
 acid seems to be 9.5 mg a day. This means no more than 10-30g
liquorice and no more than half a cup of liquorice tea a day.43
Antibiotics
Antibiotics are widely prescribed in medical practice. Many of 
them  induce  or  are  subject  to  interactions  that  may  diminish 
their anti-infectious efficiency or elicit toxic effects. Food intake 
can  influence  the  effectiveness  of  an  antibiotic.44  Avoid  co-
administration of antibiotics with milk products which are rich 
sources  of  divalent  ions,  such  as  calcium  and  magnesium  that 
complex with some antibiotics and prevent their absorption. The 
intake  of  dairy  products,  however,  needs  to  be  monitored  and 
encouraged with appropriate consideration of specific antibiotics 
involved.45
A  number  of  studies  give  evidence  that  fluoroquinolones 
forming slightly soluble complex with metal ions of food show 
reduced  bioavailability.46  Casein  and  calcium  present  in  milk 
decrease the absorption of ciprofloxacin.47 The effect of interaction 
of five fruit juices on the dissolution and absorption profiles of 
ciprofloxacin  tablets  were  determined.  It  was  found  that  the 
absorption of ciprofloxacin (500 mg) tablets can be reduced by 
concomitant  ingestion  of  the  GFJ.48  Therefore,  to  avoid  drug 
therapeutic failures and subsequent bacterial resistance as a result 
of sub-therapeutic level of the drug in the systemic circulation, 
ingestion of the juice with ciprofloxacin should be discouraged.48 
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Azithromycin  absorption  is  decreased  when  taken  with  food, 
resulting  in  a  43%  reduction  in  bioavailability.39  Tetracycline 
should be taken one hour before or two hours after meals, and 
not taken with milk because it binds calcium and iron, forming 
insoluble  chelates,  and  influencing  its  bioavailability.39,49,50  The 
effect of milk added to coffee or black tea on the bioavailability of 
tetracycline was evaluated in healthy individuals. Results showed 
that  even  a  little  quantity  of  milk  containing  extremely  small 
amounts of calcium severely impair the absorption of the drug, so 
that the presence of this metal ion should be carefully controlled in 
order to avoid decreasing the available tetracycline.51
Food-drug interactions may reduce the bioavailability of drugs 
taken after meals (negative food effects). However, enteric-coated 
tablets that start to disintegrate when they reach the middle-to-
lower  region  of  the  small  intestine  could  reduce  negative  food 
effects. Results indicated that food-drug interactions were avoided 
by separating the main absorption site of drugs from that of food 
components.52
Analgesics and Antipyretics
Analgesics and antipyretics are used to treat mild to moderate 
pain and fever. For rapid relief, acetaminophen should be taken 
in an empty stomach because food may slow the body absorption 
of  acetaminophen.  Co-administration  of  acetaminophen  with 
pectin delays its absorption and onset.53 NSAIDs like ibuprofen, 
naproxen, ketoprofen and others can cause stomach irritation and 
thus they should be taken with food or milk. Avoid or limit the use 
of alcohol because chronic alcohol use can increase the risk of liver 
damage or stomach bleeding.39 The absorption of ibuprofen and 
oxycodone when given in the combination tablet was affected by 
the concomitant ingestion of food.54
The Cmax and AUC0-alpha of ibuprofen were significantly increased 
after single and multiple doses of Coca-Cola, thereby indicating 
increased extent of absorption of ibuprofen. The daily dosage and 
frequency of ibuprofen must be reduced when administered with 
Coca-Cola.55 Food intake did not appear to affect the extent of 
absorption (ie, total exposure) of oral Diclofenac potassium soft 
gelatin capsule at doses.56
Bronchiodilators
Bronchodilators  like  theophylline,  albuterol,  and  epinephrine 
possess  different  effects  with  food.  The  effect  of  food  on 
theophylline  medications  can  vary  widely.  High-fat  meals  may 
increase  the  amount  of  theophylline  in  the  body,  while  high-
carbohydrate  meals  may  decrease  it.  Avoid  alcohol  if  taking 
theophylline  medications  because  it  can  increase  the  risk  of 
side effects such as nausea, vomiting, headache and irritability. 
Avoid eating or drinking large amounts of foods and beverages 
that contain caffeine (e.g., chocolate, colas, coffee, and tea) since 
theophylline is a xanthine derivative and these substances also 
contain  xanthine.  Hence  consuming  large  amounts  of  these 
substances while taking theophylline, increases the risk of drug 
toxicity.39  Additionally,  both  oral  bronchodilators  and  caffeine 
stimulate the central nervous system.57 Patients may be advised 
not to consume GFJ when taking theophylline, since it increases 
the bioavailability,58 and monitoring of plasma theophylline levels 
in patients consuming GFJ might be helpful in better management 
of patient care.59
Antihistamines
Fexofenadine,  loratadine,  rupatadine,  cimetidine  cetirizine,  are 
all antihistamines.60 It is best to take prescription antihistamines 
on an empty stomach to increase their effectiveness. Rupatadine 
is commonly used for the management of diseases with allergic 
inflammatory  conditions.  A  study  indicates  that  concomitant 
intake of food with a single 20 mg oral dose of rupatadine exhibits 
a significant increase in rupatadine bioavailability.61 Cimetidine 
is  given  with  food  to  assist  the  maintenance  of  a  therapeutic 
blood concentration. A fraction of cimetidine is absorbed in the 
presence  of  food,  allowing  the  remaining  drug  to  be  dissolved 
once the gut is cleared. Thus, therapeutic levels are maintained 
throughout the dosing interval.62,63 A study was conducted on a 
latest molecule esomeprazole (acid-reducer), and it was observe 
that its bioavailability was reduced when taken within 15 min 
before eating a high-fat meal vs. that while fasting. 64
Antitubercular Drugs
Anti-tubercular drugs like isoniazid have been associated with 
tyramine and histamine interactions.65 Inhibition of monoamine 
oxidase and histaminase by isoniazid can cause significant drug-
food interactions. Food greatly decreases isoniazid bioavailability.66 
Oleanolic  acid,  a  triterpenoid  exists  widely  in  food,  medicinal 
herbs and other plants, has antimycobacterial activity against the 
Mycobacterium tuberculosis, when administered with isoniazid, it 
exerts synergistic effect.67 
High fat meals decrease the serum concentration of cycloserine, 
a  bacteriostatic  anti-tubercular  drug  and  results  in  incomplete 
eradication of bacteria.68
Antidiabetics
Glimepiride is an antidiabetic and a new generation sulfonylurea 
derivative  should  be  administered  with  breakfast  or  the  first 
main  meal  of  the  day.  It  has  absolute  bioavailability  and  the 
absence  of  food  interaction  guarantee  highly  reproducible 
pharmacokinetics.69 Immediate release glipizide should be taken 
30 minutes before meals. However, extended release tablets should 
be taken with breakfast.70 The maximum effectiveness of acarbose, 
an alpha-glucosidase inhibitor is attained when the drug is taken 
immediately at the start of each meal (not half an hour before or 
after), because it delays the carbohydrate absorption by inhibiting 
the enzyme alpha-glucosidase.35Oman Medical Specialty Board
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Thyroxine
Recent  evidence  pointed  out  the  role  of  gastric  acid  secretion 
on the subsequent intestinal absorption of thyroxine in relation 
with the timing of food ingestion as well as with pH impairment 
associated to frequent gastric disorders like Helicobacter pylori 
infection and gastric atrophy.71 Levothyroxine is a derivative of 
thyroxine.  Grapefruit  juice  may  slightly  delay  the  absorption 
of levothyroxine, but it seems to have only a minor effect on its 
bioavailability. Accordingly, the clinical relevance of the grapefruit 
juice-levothyroxine interaction is likely to be small.72
Drug interactions may be theoretical or clinically relevant. A 
summary table is given to highlight some significant food-drug 
interactions. (Table 1) 
Some may be taken advantage of, to the benefit of patients, but 
more commonly drug interactions result in unnecessary adverse 
events. Fortunately, undesirable drug interactions can be prevented. 
Becoming more familiar with potential drug interactions can help 
clinicians predict and explain a patient’s response to medications.73 
Significant  food  effects  complicate  development  of  new  drugs, 
especially when clinical plans require control and/or monitoring 
of food intake in relation to dosing. The prediction of whether a 
drug or drug product will show human food effect is challenging.74
Table 1: Summary of some significant Food-Drug Interactions 
Drugs Food Drug-Food Interaction
WARFARIN High-protein diet raise serum albumin levels, decrease in international 
normalized ratio (INR)
Vegetables containing vitamin k interferes with the effectiveness and safety of warfarin therapy.
Charbroiled decrease warfarin activity
Cooked onions increase warfarin activity
Cranberry juice  elevated INR without bleeding in elderly patient
Leafy green vegetables thromboembolic complications may develop
Charbroiled decrease warfarin activity
MONOAMNINE OXIDASES Tyramine-containing food1 hypertensive crisis
PROPRANOLOL Rich protein food serum level may be increased
CELIPROLOL Orange juice the intestinal absorption is inhibited
ACES INHIBITORS Empty stomach absorption  is increased
CA2 CHANNEL Grape fruit juice increases the bioavailability
ANTIBIOTICS with milk products2 that complex with some antibiotics and prevent their 
absorption. reduced bioavailability
ACETAMINOPHEN Pectin  delays its absorption and onset
NSAIDS Alcohol can increase risk of liver damage or stomach bleeding
Beverages the c max and auc0-alpha  significantly increased3
THEOPHYLINE High-fat meal and grape fruit juice increase bioavailability
Caffeine increases the risk of drug toxicity
ESOMEPRAZOLE High-fat meal bioavailability was reduced
CIMETIDINE, RUPATADINE with food(any type) increase bioavailability
ISONIAZIDE Plantsmedicinal herbsoleanolic acid exerts synergistic effect
CYCLOSERINE High fat meals decrease the serum concentration
ESOMEPRAZOLE High-fat meal bioavailability was reduced
CIMETIDINE, RUPATADINE with food(any type) increase bioavailability
ISONIAZIDE Plantsmedicinal herbsoleanolic acid exerts synergistic effect
CYCLOSERINE High fat meals decrease the serum concentration
GLIMEPIRIDE with breakfast absolute bioavailability
ACARBOSE, at start of each meal maximum effectiveness
MERCAPTOPURINE Cow's milk4 reduce bioavailability
TAMOXIFEN Sesame seeds negatively interferes with tamoxifen in inducing regression of 
established mcf-7 tumor size but beneficially interacts with 
tamoxifen on bone in ovariectomized athymic mice
LEVOTHYROXINE Grapefruit juice delay the absorption5
GLIMEPIRIDE with breakfast absolute bioavailabilityOman Medical Specialty Board
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Antitumor Drugs 
Mercaptopurine is a purine analog used for acute lymphoblastic 
leukemia  and  chronic  myelogenous  leukemias.  Since  it  is 
inactivated  by  xanthine  oxidase  (XO),  concurrent  intake  of 
substances containing XO may potentially reduce bioavailability 
of mercaptopurine. Cow’s milk is known to contain a high level of 
XO. This interaction may be clinically significant. Therefore most 
patients should try to separate the timing of taking mercaptopurine 
and drinking milk.75
Tamoxifen  is  a  successful  anti-tumor  agent.  If  taken  with 
sesame seeds, it negatively interferes with tamoxifen in inducing 
regression  of  established  MCF-7  tumor  size  but  beneficially 
interacts  with  tamoxifen  on  bone  in  ovariectomized  athymic 
mice.76 Xue et al. had compared the influence of dietary elements 
on  cancer  progression,  chemotherapy  efficacy,  and  toxicity, 
particularly severe, late onset diarrhea related to irinotecan (CPT-
11) treatment. They suggest that glutamine and n-3 fatty acids 
might be potentially useful adjuncts with CPT-11 treatment.77
Conclusion
A large number of drugs are introduced every year. Food-drug 
interactions  can  produce  negative  effects  in  safety  and  efficacy 
of drug therapy, as well in the nutritional status of the patient. 
Generally  speaking,  drug  interactions  are  to  be  avoided,  due 
to  the  possibility  of  poor  or  unexpected  outcomes.  Like  food, 
drugs taken by mouth must be absorbed through the lining of 
the stomach or the small intestine. Consequently, the presence 
of food in the digestive tract may reduce absorption of a drug. 
Often, such interactions can be avoided by taking the drug 1 hour 
before or 2 hours after eating. Like drugs, foods are not tested as 
comprehensively so they may interact with prescription or over-
the-counter  drugs.  The  authors  would  suggest  patients  to  tell 
their doctors and pharmacists about their food intake and dietary 
supplements so that interactions can be avoided.
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